Research Paper Volume 9, Issue 5 pp 1375—1385

A decline in female baboon hypothalamo-pituitary-adrenal axis activity anticipates aging

Shanshan Yang2,3, , Kenneth G. Gerow4, , Hillary F. Huber3, , McKenna M. Considine3, , Cun Li1,3, , Vicki Mattern1, , Anthony G. Comuzzie1, , Stephen P. Ford5, , Peter W. Nathanielsz1,3, ,

  • 1 Texas Biomedical Research Institute, San Antonio, TX 78227, USA
  • 2 Department of Neurology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, China
  • 3 Texas Pregnancy and Life-course Health Research Center, Department of Animal Sciences, University of Wyoming, Laramie, WY 82071, USA
  • 4 Department of Statistics, University of Wyoming, Laramie, WY 82071, USA
  • 5 Department of Animal Sciences, University of Wyoming, Laramie, WY 82071, USA

Received: December 15, 2016       Accepted: April 29, 2017       Published: May 9, 2017      

https://doi.org/10.18632/aging.101235
How to Cite

Copyright: © 2017 Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Stressors that disrupt homeostasis advance aging. Glucocorticoids regulate multiple processes that determine the aging trajectory. Debate exists regarding life-course circulating glucocorticoid concentrations. Rodent and nonhuman primate studies indicate circulating glucocorticoids fall from early life. We measured fasting morning cortisol in 24 female baboons (6-21 years, human equivalent ~18-70). We also quantified hypothalamic paraventricular nuclear (PVN) arginine vasopressin (AVP), corticotropin-releasing hormone, steroid receptors, and pituitary proopiomelanocortin immunohistochemically in 14 of these females at 6-13 years. We identified significant age-related 1) linear fall in cortisol and PVN AVP from as early as 6 years; 2) increased PVN glucocorticoid and mineralocorticoid receptors; 3) increased PVN 11β-hydroxysteroid dehydrogenase 1 and 2, regulators of local cortisol production, and 4) decreased pituitary proopiomelanocortin. Our data identify increased age-related negative feedback and local PVN cortisol production as potential mechanisms decreasing PVN drive to hypothalamo-pituitary-adrenal axis activity that result in the age-related circulating cortisol fall. Further studies are needed to determine whether the cortisol fall 1) causes aging, 2) protects by slowing aging, or 3) is an epiphenomenon unrelated to aging processes. We conclude that aging processes are best studied by linear life-course analysis beginning early in life.

Abbreviations

11βHSD: 11beta hydroxysteroid dehydrogenase Type 1; 11βHSD2: 11beta hydroxysteroid dehydrogenase Type 2; AVP: Arginine vasopressin; CRH: Corticotropin-releasing hormone; GR: Glucocorticoid receptor; H6PD: Hexose-6-phosphate dehydrogenase; HPAA: Hypothalamo-pituitary-adrenal axis; MR: Mineralo-corticoid receptor; p-GR: Phospho-glucocorticoid receptor; PND: Postnatal days; POMC: Pro-opiomelanocortin; PVN: Paraventricular nucleus.